Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer

Archives of Surgery

Volumn 144, Issue 2, 2009, Pages 129-134

  Castaldo, Eric T ^a   Parikh, Alexander A ^a   Pinson, C Wright ^a   Feurer, Irene D ^a   Merchant, Nipun B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECTUM CARCINOMA; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT RESPONSE;

ADENOCARCINOMA; AGED; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; SEER PROGRAM; TREATMENT OUTCOME;

EID: 61549088149     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2008.549     Document Type: Article

References (33)

1. National Cancer Institute. A Snapshot of Colorectal Cancer. Bethesda, MD: National Cancer Institute; 2006.
2. Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Can cer Inst. 1988;80(1):21-29.
3. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 1985;312(23):1465-1472.
4. Stockholm Colorectal Cancer Study Group. Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol. 1996;3(5):423-430.
5. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336(14):980-987.
6. Cedermark B, Johansson H, Rutqvist LE, Wilking N; Stockholm Colorectal Cancer Study Group. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma: a prospective randomized trial. Cancer. 1995; 75(9):2269-2275.
7. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resect- able rectal cancer. N Engl J Med. 2001;345(9):638-646.
8. Sauer R, Becker H, Hohenberger W, et al; German Rectal Cancer Study Group. Preoperative vs postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731-1740.
9. Cammà C, Giunta M, Fiorica F, Pagliaro L, Craxl̀ A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA. 2000;284(8): 1008-1015.
10. Mohiuddin M, Winter K, Mitchell E, et al; Radiation Therapy Oncology Group Trial 0012. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol. 2006;24(4):650-655.
11. Rullier E, Goffre B, Bonnel C, Zerbib F, Caudry M, Saric J. Preoperative radio-chemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg. 2001;234(5):633-640.
12. Ruo L, Tickoo S, Klimstra DS, et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg. 2002;236(1):75-81.
13. Balch GC, Mithani SK, Shyr Y, et al. Prognostic significance of response to neoadjuvant chemoradiation therapy for rectal cancer [abstract 1047]. Proc Am Soc Clin Oncol. 2003;22:261.
14. Garcfa-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothen-berger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum. 2003;46(3):298-304.
15. Janjan NA, Abbruzzese J, Pazdur R, et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol. 1999;51(2):153-160.
16. Shia J, Guillem JG, Moore HG, et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol. 2004;28(2):215-223.
17. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program: SEER *Stat Database: Incidence, SEER 17 Regs Public-Use, Nov 2005 Sub (1973-2003 varying), Linked To County Attributes, Total US, 1969-2003 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission. http://www.seer.cancer.gov. Accessed June 1, 2007.
18. National Cancer Institute. SEER: About the SEER Program. Bethesda, MD: National Cancer Institute; 2006.
19. Greene FL, Page DL, Fleming ID, et al, eds; American Joint Committee on Cancer. Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
20. Guillem JG, Chessin DB, Cohen AM, etal. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg. 2005;241(5):829-838.
21. Kim CJ, Yeatman TJ, Coppola D, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg. 2001;234(3):352-359.
22. Schell SR, Zlotecki RA, Mendenhall WM, Marsh RW, Vauthey JN, Copeland EM III. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg. 2002;194(5):584-591.
23. Habr-Gama A, Perez RO, Nadalin W, et al. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg. 2005;9(1):90-101.
24. Habr-Gama A, Perez RO, Proscurshim I, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg. 2006;10(10):1319-1329.
25. Moore HG, Gittleman AE, Minsky BD, et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum. 2004;47(3):279-286.
26. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B; Stockholm Colorectal Cancer Study Group. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer. 2001;92(4):896-902.
27. Hildebrandt U, Klein T, Feifel G, Schwarz HP, Koch B, Schmitt RM. Endosonography of pararectal lymph nodes: in vitro and in vivo evaluation. Dis Colon Rectum. 1990;33(10):863-868.
28. Thaler W, Watzka S, Martin F, et al. Preoperative staging of rectal cancer by endoluminal ultrasound vs magnetic resonance imaging: preliminary results of a prospective, comparative study. Dis Colon Rectum. 1994;37(12):1189-1193.
29. Tio TL, Coene PP, van Delden OM, Tytgat GN. Colorectal carcinoma: preoperative TNM classification with endosonography. Radiology. 1991;179(1):165-170.
30. Waizer A, Powsner E, Russo I, et al. Prospective comparative study of magnetic resonance imaging vs transrectal ultrasound for preoperative staging and follow-up of rectal cancer: preliminary report. Dis Colon Rectum. 1991;34(12): 1068-1072.
31. Wudel LJ Jr, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg. 2002;137 (5):550-556.
32. Polite BN, Dignam JJ, Olopade OI. Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites. Med Clin North Am. 2005;89(4):771-793.
33. Polite BN, Dignam JJ, Olopade OI. Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol. 2006; 24(14):2179-2187.